FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAustralian Clinical Labs Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ACL.AX
Australian Clinical Labs Limited Stock AnalysisComprehensive stock analysis for Australian Clinical Labs Limited (ACL.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisACL.AX
ACL.AX
Australian Clinical Labs Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ACL.AX
  1. Home
  2. Stocks
  3. Australian Clinical Labs Limited

Australian Clinical Labs Limited

🇦🇺ACL.AX•ASX

Australian Clinical Labs Limited

🇦🇺ACL.AX•ASX
P/E ratio
26.94

Your view on ACL.AX

P/E
26.94
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Australian Clinical Labs Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Melinda McGrath
Headquarters
1868-1892 Dandenong Road, Clayton, VIC, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Melinda McGrath
Headquarters
1868-1892 Dandenong Road, Clayton, VIC, AU
Description

Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening.

Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services.

ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation.

The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Australian Clinical Labs Limited from FRC's valuation model, read against the market price. ACL.AX last traded at AUD 2.38, 26.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Australian Clinical Labs Limited. Starting points for Australian Clinical Labs Limited: P/E 26.9, EPS AUD 0.12, beta 0.82 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Australian Clinical Labs Limited. Australian Clinical Labs Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Australian Clinical Labs Limited. Trailing twelve-month EPS for Australian Clinical Labs Limited stands at AUD 0.12. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · AUD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrSep 2025Next QtrDec 2025Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 0.00AUD 0.07AUD 0.19AUD 0.21
Low estimateAUD 0.00AUD 0.07AUD 0.19AUD 0.20
High estimateAUD 0.00AUD 0.07AUD 0.20AUD 0.22
No. of analysts0166
Year-ago EPS——AUD 0.12—
Growth——+59.4%—

Revenue Estimate

RevenueCurrent QtrSep 2025Next QtrDec 2025Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 386.06MAUD 378.48MAUD 758.06MAUD 788.71M
Low estimateAUD 386.06MAUD 378.48MAUD 754.57MAUD 777.71M
High estimateAUD 386.06MAUD 378.48MAUD 762.99MAUD 800.78M
No. of analysts2177
Year-ago revenue——AUD 729.52M—
Growth——+3.9%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Australian Clinical Labs Limited. Australian Clinical Labs Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ACL.AX19 companies · 8 funds
Compare ACL.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
BDX.AXBCAL Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
CTE.AXCryosite LimitedHealthcareMedical - Diagnostics & Research—
GSS.AXGenetic Signatures LimitedHealthcareMedical - Diagnostics & Research—
HLS.AXHealius LimitedHealthcareMedical - Diagnostics & Research—
IIQ.AXINOVIQ LtdHealthcareMedical - Diagnostics & Research—
RHY.AXRhythm Biosciences LimitedHealthcareMedical - Diagnostics & Research—
SHL.AXSonic Healthcare LimitedHealthcareMedical - Diagnostics & Research—
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
ILMNIllumina, Inc.HealthcareNASDAQ$31.8B
IMDXInsight Molecular Diagnostics Inc.HealthcareNASDAQ$52.1M
IME.AXImExHS LimitedHealthcareASX—
IMMVFImmunovia AB (publ)HealthcareOTC$6.1M
IQVIQVIA Holdings Inc.HealthcareNYSE$42.5B
ISPCiSpecimen Inc.HealthcareNASDAQ$1.3M
IVROInVitro InternationalHealthcareOTC$1.8M
IZO.CNIzotropic CorporationHealthcareCNQ$20.6M
IZOZFIzotropic CorporationHealthcareOTC$11.9M
JMPHFLeveljump Healthcare Corp.HealthcareOTC$15.2M
LDDDLongduoduo Company LimitedHealthcareOTC$15.3M
LHLabcorp Holdings Inc.HealthcareNYSE$30.1B
ETFs holding Australian Clinical Labs Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.00%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.00%
VSSVanguard FTSE All-World ex-US Small-Cap ETF$11.6B in assets0.01%
SCHCSchwab International Small-Cap Equity ETF$5.4B in assets0.02%
DDLSWisdomTree Dynamic International SmallCap Equity ETF$410M in assets0.06%
DTHWisdomTree International High Dividend Fund$635M in assets0.02%
AVDSAvantis International Small Cap Equity ETF$379M in assets0.02%
DWMWisdomTree International Equity Fund$651M in assets0.01%

Largest holders first, then the funds most concentrated in ACL.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Australian Clinical Labs Limited. Coverage tracks Australian Clinical Labs Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Australian Clinical Labs Limited.

ACL.AX AnalysisFair
Past
3
Growth
3
Health
3
Profit
3
Value
1

News

Latest Market News